标题
Targeting cancer metabolism in the era of precision oncology
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 21, Issue 2, Pages 141-162
出版商
Springer Science and Business Media LLC
发表日期
2021-12-04
DOI
10.1038/s41573-021-00339-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth
- (2021) Katelyn D. Miller et al. CANCER RESEARCH
- Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma
- (2021) Zongwei Li et al. Cell Metabolism
- The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
- (2021) Arafath K. Najumudeen et al. NATURE GENETICS
- Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy
- (2021) Mylène Tajan et al. Nature Communications
- CANTATA: Primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839) + cabozantinib versus Pbo + cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapies.
- (2021) Nizar M. Tannir et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure based discovery of novel hexokinase 2 inhibitors
- (2020) Yang Liu et al. BIOORGANIC CHEMISTRY
- Role of monocarboxylate transporters in regulating metabolic homeostasis in the outer retina: Insight gained from cell‐specific Bsg deletion
- (2020) John Y. S. Han et al. FASEB JOURNAL
- mTOR at the nexus of nutrition, growth, ageing and disease
- (2020) Grace Y. Liu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity
- (2020) Dalton Hermans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy
- (2020) Nobu Oshima et al. Cell Reports
- Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation
- (2020) Matthew C Johnson et al. eLife
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study
- (2020) Arthur Bergman et al. Clinical Pharmacology in Drug Development
- Serine Catabolism Feeds NADH when Respiration Is Impaired
- (2020) Lifeng Yang et al. Cell Metabolism
- SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
- (2020) Juan C. García-Cañaveras et al. LEUKEMIA
- Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study
- (2020) Michael Rosenzweig et al. LEUKEMIA & LYMPHOMA
- Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer
- (2020) Seth J Parker et al. Cancer Discovery
- Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
- (2020) Ubaldina Galli et al. Frontiers in Pharmacology
- Structural Evidence for Isoform-Selective Allosteric Inhibition of Lactate Dehydrogenase A
- (2020) Anders Friberg et al. ACS Omega
- In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model
- (2020) Xiaowen Guan et al. AAPS Journal
- Mitochondrial Metabolism as a Target for Cancer Therapy
- (2020) Karthik Vasan et al. Cell Metabolism
- Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights
- (2020) Sachin Puri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of lipogenic enzymes as a potential therapy against cancer
- (2020) Nicolás Montesdeoca et al. FASEB JOURNAL
- Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
- (2020) Min-Hee Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
- (2020) Jackie E. Bader et al. MOLECULAR CELL
- Mitochondrial ubiquinol oxidation is necessary for tumour growth
- (2020) Inmaculada Martínez-Reyes et al. NATURE
- Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition
- (2020) Bryan Ngo et al. Cancer Discovery
- Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat
- (2020) Annette E. Allen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Quantitative Analysis of the Physiological Contributions of Glucose to the TCA Cycle
- (2020) Shiyu Liu et al. Cell Metabolism
- Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties
- (2020) Ganesha Rai et al. JOURNAL OF MEDICINAL CHEMISTRY
- JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function
- (2020) Kentaro Okunushi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase
- (2020) Gabrielle McDonald et al. MOLECULAR CANCER THERAPEUTICS
- Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
- (2020) Keith A. Lawson et al. NATURE
- Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion
- (2020) Yi-Ru Yu et al. NATURE IMMUNOLOGY
- A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
- (2020) Haojie Jin et al. eLife
- Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies
- (2020) Milena M. Petrović et al. BIOORGANIC CHEMISTRY
- Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
- (2020) Nan Wang et al. CELL
- Determinants of Tissue-Specific Metabolic Adaptation of T Cells
- (2020) Siva Karthik Varanasi et al. Cell Metabolism
- Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells
- (2020) Xiphias Ge Zhu et al. Cell Metabolism
- Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer
- (2020) Douglas E. Biancur et al. Cell Metabolism
- In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1
- (2020) Emily M. Christensen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis
- (2020) Rui Jin et al. MOLECULAR CANCER THERAPEUTICS
- Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
- (2020) Shauni Lien Geeraerts et al. MOLECULAR CANCER THERAPEUTICS
- IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
- (2020) Friedrich Hahn et al. Viruses-Basel
- Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations
- (2020) Ryan C. Augustin et al. Cancers
- Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer
- (2020) Deanna N. Edwards et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis
- (2020) Mengzhu Zheng et al. PHARMACOLOGICAL RESEARCH
- Suppression of hepatocellular carcinoma by mycophenolic acid in experimental models and in patients
- (2019) Kan Chen et al. TRANSPLANTATION
- High-fructose corn syrup enhances intestinal tumor growth in mice
- (2019) Marcus D. Goncalves et al. SCIENCE
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs
- (2019) Lukáš Tenora et al. JOURNAL OF MEDICINAL CHEMISTRY
- An HK2 antisense oligonucleotide induces synthetic lethality in HK1-HK2+ multiple myeloma
- (2019) Shili Xu et al. CANCER RESEARCH
- Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation
- (2019) Ceren Duman et al. Cell Metabolism
- Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT 2 by antifolate drugs
- (2019) Emma Scaletti et al. FEBS LETTERS
- Phase I trial of IACS-010759 (IACS), a potent, selective inhibitor of complex I of the mitochondrial electron transport chain, in patients (pts) with advanced solid tumors.
- (2019) Timothy A Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- An allosteric mechanism for potent inhibition of human ATP-citrate lyase
- (2019) Jia Wei et al. NATURE
- The landscape of cancer cell line metabolism
- (2019) Haoxin Li et al. NATURE MEDICINE
- Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells
- (2019) Edouard Mullarky et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A fragment-like approach to PYCR1 inhibition
- (2019) Kirsty Milne et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor BI-4924 Disrupts Serine Biosynthesis
- (2019) Harald Weinstabl et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy
- (2019) Aamod S. Dekhne et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition
- (2019) Gary K. Scott et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of ACSS2 for Treatment of Cancer and Neuropsychiatric Diseases
- (2019) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma
- (2019) Choh Yeung et al. CANCER RESEARCH
- Hallmarks of Endothelial Cell Metabolism in Health and Disease
- (2019) Xuri Li et al. Cell Metabolism
- The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
- (2019) Arvin M. Gouw et al. Cell Metabolism
- A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
- (2019) Philip A Philip et al. Future Oncology
- Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study
- (2019) Timothy S Pardee et al. Future Oncology
- Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
- (2019) Rachael F. Grace et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLS2 is protumorigenic in breast cancers
- (2019) Marilia M. Dias et al. ONCOGENE
- Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
- (2019) Aamod S. Dekhne et al. MOLECULAR PHARMACOLOGY
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
- (2019) Allison R. Hanaford et al. Translational Oncology
- Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer
- (2019) Michael J. Lukey et al. Cell Reports
- Metabolic Consequences of T-cell Costimulation in Anticancer Immunity
- (2019) Alvaro Teijeira et al. Cancer Immunology Research
- Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo
- (2019) Seth T. Gammon et al. Cells
- Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
- (2019) Claire L. Bensard et al. Cell Metabolism
- Mitochondria in cancer metabolism, an organelle whose time has come?
- (2018) Rebecca G. Anderson et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors
- (2018) Jason M. Rohde et al. BIOORGANIC & MEDICINAL CHEMISTRY
- As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid
- (2018) Natalya N. Pavlova et al. Cell Metabolism
- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- (2018) Tina Cascone et al. Cell Metabolism
- A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
- (2018) Timothy S. Pardee et al. CLINICAL CANCER RESEARCH
- Targeting cancer metabolism to develop human lactate dehydrogenase ( h LDH)5 inhibitors
- (2018) Shao-Lin Zhang et al. DRUG DISCOVERY TODAY
- Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs
- (2018) Denise R. Minton et al. MOLECULAR CELL
- Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
- (2018) Javier Garcia-Bermudez et al. NATURE CELL BIOLOGY
- Aspartate is an endogenous metabolic limitation for tumour growth
- (2018) Lucas B. Sullivan et al. NATURE CELL BIOLOGY
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
- (2018) Michael L Schulte et al. NATURE MEDICINE
- Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma
- (2018) Yuki Egawa et al. PLoS One
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
- (2018) Adam J. Wolpaw et al. TRENDS IN CELL BIOLOGY
- Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer
- (2018) Yekaterina Y. Zaytseva et al. Oncotarget
- Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions
- (2018) Ashley V. Menk et al. Cell Reports
- Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
- (2018) Angelika Bröer et al. Frontiers in Pharmacology
- ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism
- (2018) Carlotta Granchi EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel human inosine 5′-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents
- (2018) Chetan P. Shah et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Double genetic disruption of lactate dehydrogenase A and B is required to ablate the ‘Warburg effect’ restricting tumor growth to oxidative metabolism
- (2018) Maša Ždralević et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- We're Not “DON” Yet: Optimal Dosing and Prodrug Delivery of6-Diazo-5-oxo-L-norleucine
- (2018) Kathryn M. Lemberg et al. MOLECULAR CANCER THERAPEUTICS
- ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism
- (2018) Zhiguang Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
- (2018) Marc O. Johnson et al. CELL
- Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids
- (2018) Michael D. Neinast et al. Cell Metabolism
- Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity
- (2018) Benjamin M. Vincent et al. Cell Reports
- Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
- (2018) Lorenzo Galluzzi et al. OncoImmunology
- Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)
- (2017) Ganesha Rai et al. JOURNAL OF MEDICINAL CHEMISTRY
- α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH)
- (2017) Séverine Ravez et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
- (2017) Angela Alistar et al. LANCET ONCOLOGY
- Activation of the Unfolded Protein Response by Lipid Bilayer Stress
- (2017) Kristina Halbleib et al. MOLECULAR CELL
- Modulating the therapeutic response of tumours to dietary serine and glycine starvation
- (2017) Oliver D. K. Maddocks et al. NATURE
- Glucose feeds the TCA cycle via circulating lactate
- (2017) Sheng Hui et al. NATURE
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
- (2017) Gregory S. Ducker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity
- (2017) Nicola J. Curtis et al. Oncotarget
- FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
- (2017) Timothy S. Heuer et al. EBioMedicine
- 2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport
- (2016) Michael L. Schulte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- (2016) Raju V. Pusapati et al. CANCER CELL
- Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876
- (2016) Holger Siebeneicher et al. ChemMedChem
- Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma
- (2016) Rana Rais et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
- (2016) Cristovão M. Sousa et al. NATURE
- A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
- (2016) Michael E Pacold et al. Nature Chemical Biology
- SF2312 is a natural phosphonate inhibitor of enolase
- (2016) Paul G Leonard et al. Nature Chemical Biology
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- (2016) Aaron Boudreau et al. Nature Chemical Biology
- Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
- (2016) Robert U Svensson et al. NATURE MEDICINE
- Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
- (2016) Roman Camarda et al. NATURE MEDICINE
- Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
- (2016) Edouard Mullarky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats
- (2016) Geraldine Harriman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
- (2016) J. R. Mayers et al. SCIENCE
- Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies
- (2016) Kristofor A. Olson et al. TRENDS IN BIOCHEMICAL SCIENCES
- Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors
- (2016) Hong Lin et al. ACS Medicinal Chemistry Letters
- Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
- (2016) Stephen L. Pinkosky et al. Nature Communications
- Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
- (2016) C. Vernieri et al. Cancer Discovery
- Structural basis for exploring the allosteric inhibition of human kidney type glutaminase
- (2016) Sarath Ramachandran et al. Oncotarget
- ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch
- (2016) Steven Zhao et al. Cell Reports
- Suppressive effects of tumor cell-derived 5′-deoxy-5′-methylthioadenosine on human T cells
- (2016) Frederik C. Henrich et al. OncoImmunology
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
- (2015) Zachary T. Schug et al. CANCER CELL
- Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
- (2015) N. V. Rajeshkumar et al. CANCER RESEARCH
- An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
- (2015) Kıvanç Birsoy et al. CELL
- A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
- (2015) Marco Y. Hein et al. CELL
- Screening and In Vitro Testing of Antifolate Inhibitors of Human Cytosolic Serine Hydroxymethyltransferase
- (2015) Alessandro Paiardini et al. ChemMedChem
- New Strategies in Renal Cell Carcinoma: Targeting the Genetic and Metabolic Basis of Disease
- (2015) R. Srinivasan et al. CLINICAL CANCER RESEARCH
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- (2015) Yan Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- X-ray structure of a mammalian stearoyl-CoA desaturase
- (2015) Yonghong Bai et al. NATURE
- Crystal structure of human stearoyl–coenzyme A desaturase in complex with substrate
- (2015) Hui Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- Crystal structure of human stearoyl–coenzyme A desaturase in complex with substrate
- (2015) Hui Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes
- (2014) Drew J. Adams et al. ACS Chemical Biology
- Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
- (2014) Hannah R. Bridges et al. BIOCHEMICAL JOURNAL
- Acetate Dependence of Tumors
- (2014) Sarah A. Comerford et al. CELL
- Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
- (2014) Han Xie et al. Cell Metabolism
- A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
- (2014) T. S. Pardee et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- A Role for the Mitochondrial Pyruvate Carrier as a Repressor of the Warburg Effect and Colon Cancer Cell Growth
- (2014) John C. Schell et al. MOLECULAR CELL
- The gut microbiota, bacterial metabolites and colorectal cancer
- (2014) Petra Louis et al. NATURE REVIEWS MICROBIOLOGY
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
- (2013) Krushna C. Patra et al. CANCER CELL
- Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
- (2013) J. R. Doherty et al. CANCER RESEARCH
- PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells
- (2013) William J. Israelsen et al. CELL
- Opportunities and Challenges in Developing Stearoyl-Coenzyme A Desaturase-1 Inhibitors as Novel Therapeutics for Human Disease
- (2013) Zaihui Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Carnitine-Acyltransferase System Inhibition, Cancer Cell Death, and Prevention of Myc-Induced Lymphomagenesis
- (2013) Annalisa Pacilli et al. JNCI-Journal of the National Cancer Institute
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
- (2012) Mariia O. Yuneva et al. Cell Metabolism
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism
- (2012) Stephen L. Pinkosky et al. JOURNAL OF LIPID RESEARCH
- Passenger deletions generate therapeutic vulnerabilities in cancer
- (2012) Florian L. Muller et al. NATURE
- Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
- (2012) Oliver D. K. Maddocks et al. NATURE
- Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism
- (2012) K. Thangavelu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model
- (2012) H-W Chen et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials
- (2010) C. Granchi et al. CURRENT MEDICINAL CHEMISTRY
- Recent Advances in Stearoyl-CoA Desaturase 1 Inhibitors for Dyslipidemia and Obesity
- (2010) Gang Liu CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
- (2010) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- (2009) Koji Oda et al. CANCER SCIENCE
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now